insights_auto
Why is ARGX down 4,09%?
Dive Deeperchevron_right
ARGX:EBR
argenx SE
€727,60
arrow_downward
-4,09%(-31,00) 1D
16 Okt., 17:39:35 GMT+2 · EUR
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGX...
Open
€759,20
High
€761,80
Low
€727,60
Mkt. cap
45,57 mjd
Avg. vol.
86,90 k
Volume
96,25 k
P/E ratio
30,95
52-wk high
€925,00
52-wk low
€568,40
EPS
€23,51
Shares outstanding
35,93 m
No. of employees
2 k
Open
€759,20
High
€761,80
Low
€727,60
Mkt. cap
45,57 mjd
Avg. vol.
86,90 k
Volume
96,25 k
P/E ratio
30,95
52-wk high
€925,00
52-wk low
€568,40
EPS
€23,51
Shares outstanding
35,93 m
No. of employees
2 k
News stories
From web sources and news partners
ad-hoc-news.de
·
5 uur gelede
Goldman lifts target for Argenx stock to EUR 959.00
Yahoo Finance
·
7 uur gelede
Zacks Investment Ideas feature highlights: Cummins, Argenx and PACCAR
ad-hoc-news.de
·
9 uur gelede
argenx sets October 22 results date as Argenx stock costs EUR 761.20
Investing.com South Africa
·
1 dag gelede
Argenx shares may move 5.5% on earnings release next week By Investing.com
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE